Search - tctmd.com

Displaying 141 - 160 of 842

Sort: Relevancy | Date

Presentation TCT 2016

Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias

Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Vivek Y. Reddy

October 30, 2016

Presentation TCT 2016

Beyond Hypertension: Autonomic Modulation Therapies for Chronic Heart Failure

Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Farrell O. Mendelsohn

October 30, 2016

$Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies$

Presentation TCT 2016

Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies

Presenter: Ajay J. Kirtane, Bryan Williams, William B. White

October 30, 2016

Presentation TCT 2016

Pacing-based Treatments of Hypertension: BackBeat Medical

Presenter: Ajay J. Kirtane, Bryan Williams, Karl-Heinz Kuck

October 30, 2016

Presentation TCT 2016

Shunt-based Technologies for Hypertension Control: The Rox Medical Program

Presenter: Ajay J. Kirtane, Bryan Williams, Paul A. Sobotka

October 30, 2016

Presentation TCT 2016

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation

Presenter: Duane S. Pinto, Dmitriy N. Feldman

October 30, 2016

Presentation TCT 2016

Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and the CALM Studies

Presenter: Ajay J. Kirtane, Bryan Williams, Wilko Spiering

October 30, 2016

Presentation TCT 2016

Carotid Sinus Stimulation: Critical Analysis of the 1st and 2nd Generation CVRx Device Results

Presenter: Ajay J. Kirtane, Bryan Williams, Atul Pathak

October 30, 2016

Presentation TCT 2016

Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates?

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Martin B. Leon

October 30, 2016

Presentation TCT 2016

Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness?

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Justin E. Davies

October 30, 2016

Presentation TCT 2016

Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Kona WAVE IV Trial

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Roland E Schmieder

October 30, 2016

Presentation TCT 2016

The Smoker's Paradox Revisited: A Five-Year Patient-Level Pooled Analysis of 17 Randomized Controlled Trials

Presenter: Mayank Yadav

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Laura Mauri

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, William B. White

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari

October 30, 2016

Presentation TCT 2016

Device Overview and Ongoing Study Design: Boston Scientific REINFORCE

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Ajay J. Kirtane

October 30, 2016

Presentation TCT 2016

Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Bryan Williams

October 30, 2016

Presentation TCT 2016

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Horst Sievert

October 30, 2016

Presentation TCT 2016

Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year

Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Felix Mahfoud

October 30, 2016

Advertisement

Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias

Beyond Hypertension: Autonomic Modulation Therapies for Chronic Heart Failure

Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies

Pacing-based Treatments of Hypertension: BackBeat Medical

Shunt-based Technologies for Hypertension Control: The Rox Medical Program

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation

Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and the CALM Studies

Carotid Sinus Stimulation: Critical Analysis of the 1st and 2nd Generation CVRx Device Results

Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates?

Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness?

Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial

Device Overview and Ongoing Study Design: Kona WAVE IV Trial

The Smoker's Paradox Revisited: A Five-Year Patient-Level Pooled Analysis of 17 Randomized Controlled Trials

Device Overview and Ongoing Study Design: Recor RADIANCE HTN Study

Device Overview and Ongoing Study Design: St. Jude's EnligHTN Program

Device Overview and Ongoing Study Design: Medtronic GLOBAL SYMPLICITY SPYRAL HTN Trial Program

Device Overview and Ongoing Study Design: Boston Scientific REINFORCE

Overcoming Clinical Design Issues: What to Look for (and Demand) in Ongoing and Future Hypertension Device Trials

Overcoming RDN Catheter Design Limitations: Issues and Spectrum of Devices

Renal Denervation for Hypertension: New Insights and A Progress Report From Last Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content